glp 1 agonists Resmetirom and GLP-1 for MASH: complementary rather than exclusive What You Should Know Before
Description
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo
or oral administration
Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
Results Reducing dose frequency does not commensurately reduce weight loss
Shima Hadidchi
They are primarily used in the management of type 2 diabetes (T2D).
